Pricing
Login
Home
Charts
Search
Watchlist
Products

Glenmark Pharmaceuticals Ltd

GLENMARK
₹2,648.00+1.51%20 Nov 2026
Reports
Pharma Formulations

Glenmark Pharmaceuticals Ltd

GLENMARK
₹2,648.00
+1.51%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹74,733Cr
Close
Close Price
₹2,648.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
51.49
PS
Price To Sales
4.69
Revenue
Revenue
₹15,937Cr
Rev Gr TTM
Revenue Growth TTM
-0.11%
PAT Gr TTM
PAT Growth TTM
43.71%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
2,5073,0633,2443,4343,3883,2563,2646,0473,9013,7714,0184,247
Growth YoY
Revenue Growth YoY%
-19.12.16.87.135.16.30.676.115.215.823.1-29.8
Expenses
ExpensesCr
2,7152,5592,6562,8322,7872,6952,6843,6873,0313,0083,2143,384
Operating Profit
Operating ProfitCr
-2095045886026005615812,360870763805864
OPM
OPM%
-8.316.518.117.517.717.217.839.022.320.220.020.3
Other Income
Other IncomeCr
-31326313931-361-297-1,184-140-18466-281
Interest Expense
Interest ExpenseCr
13414940485267586641435464
Depreciation
DepreciationCr
147151118120123125130141154148173180
PBT
PBTCr
-521531462473456896967534388643338
Tax
TaxCr
-721,7691221181084493571318616174
PAT
PATCr
-331-1,214340354348447610403301483264
Growth YoY
PAT Growth YoY%
-213.8-201.296.5675.8205.2100.4-86.272.215.96,779.4928.0-56.8
NPM
NPM%
-13.2-39.610.510.310.30.11.410.110.38.012.06.2
EPS
EPS₹
-12.4-43.212.112.612.30.21.721.614.310.717.19.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
2,5073,0633,2443,4343,3883,2563,2646,0473,9013,7714,0184,247
Growth YoY
Revenue Growth YoY%
-19.12.16.87.135.16.30.676.115.215.823.1-29.8
Expenses
ExpensesCr
2,7152,5592,6562,8322,7872,6952,6843,6873,0313,0083,2143,384
Operating Profit
Operating ProfitCr
-2095045886026005615812,360870763805864
OPM
OPM%
-8.316.518.117.517.717.217.839.022.320.220.020.3
Other Income
Other IncomeCr
-31326313931-361-297-1,184-140-18466-281
Interest Expense
Interest ExpenseCr
13414940485267586641435464
Depreciation
DepreciationCr
147151118120123125130141154148173180
PBT
PBTCr
-521531462473456896967534388643338
Tax
TaxCr
-721,7691221181084493571318616174
PAT
PATCr
-331-1,214340354348447610403301483264
Growth YoY
PAT Growth YoY%
-213.8-201.296.5675.8205.2100.4-86.272.215.96,779.4928.0-56.8
NPM
NPM%
-13.2-39.610.510.310.30.11.410.110.38.012.06.2
EPS
EPS₹
-12.4-43.212.112.612.30.21.721.614.310.717.19.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
7,5629,0799,0749,86510,64110,94412,30511,58311,81313,32216,98315,937
Growth
Revenue Growth%
14.120.1-0.18.77.92.912.4-5.92.012.827.5-0.1
Expenses
ExpensesCr
6,1257,0437,4598,2808,9438,8609,9859,94810,61810,97012,41012,636
Operating Profit
Operating ProfitCr
1,4372,0371,6151,5861,6982,0842,3201,6351,1952,3514,5723,301
OPM
OPM%
19.022.417.816.116.019.118.914.110.117.626.920.7
Other Income
Other IncomeCr
20-449137519295-94-477-61-259-1,805-540
Interest Expense
Interest ExpenseCr
179237286335377353298349516207209202
Depreciation
DepreciationCr
234264302326417444487569582486573656
PBT
PBTCr
1,0441,4911,1191,3011,0961,3821,441240371,3991,9851,903
Tax
TaxCr
3013833153763204124483291,867352623452
PAT
PATCr
7431,109804925776970994-90-1,8311,0471,3621,451
Growth
PAT Growth%
56.449.2-27.515.1-16.125.02.4-109.0-1,944.3157.230.143.7
NPM
NPM%
9.812.28.99.47.38.98.1-0.8-15.57.98.09.1
EPS
EPS₹
25.639.328.532.827.534.433.410.5-53.237.148.351.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
7,5629,0799,0749,86510,64110,94412,30511,58311,81313,32216,98315,937
Growth
Revenue Growth%
14.120.1-0.18.77.92.912.4-5.92.012.827.5-0.1
Expenses
ExpensesCr
6,1257,0437,4598,2808,9438,8609,9859,94810,61810,97012,41012,636
Operating Profit
Operating ProfitCr
1,4372,0371,6151,5861,6982,0842,3201,6351,1952,3514,5723,301
OPM
OPM%
19.022.417.816.116.019.118.914.110.117.626.920.7
Other Income
Other IncomeCr
20-449137519295-94-477-61-259-1,805-540
Interest Expense
Interest ExpenseCr
179237286335377353298349516207209202
Depreciation
DepreciationCr
234264302326417444487569582486573656
PBT
PBTCr
1,0441,4911,1191,3011,0961,3821,441240371,3991,9851,903
Tax
TaxCr
3013833153763204124483291,867352623452
PAT
PATCr
7431,109804925776970994-90-1,8311,0471,3621,451
Growth
PAT Growth%
56.449.2-27.515.1-16.125.02.4-109.0-1,944.3157.230.143.7
NPM
NPM%
9.812.28.99.47.38.98.1-0.8-15.57.98.09.1
EPS
EPS₹
25.639.328.532.827.534.433.410.5-53.237.148.351.4
Sales CAGR
1 Year27%
3 Years14%
5 Years9%
TTM0%
EBITDA CAGR
1 Year94%
3 Years41%
5 Years17%
TTM-20%
PAT CAGR
1 Year30%
3 Years-
5 Years7%
TTM44%
Avg. ROCE
1 Year20%
3 Years13%
5 Years12%
TTM17%
CFO / EBITDA
1 Year75%
3 Years29%
5 Years34%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
282828282828282828282828
Reserves
ReservesCr
3,6014,4645,1355,5776,0427,0369,0589,4467,8208,82110,48411,184
Current Liabilities
Current LiabilitiesCr
3,9992,7033,2884,0214,1264,2014,6895,1055,8195,9676,3767,507
Non Current Liabilities
Non Current LiabilitiesCr
2,5644,5694,1443,6634,4894,3382,9564,4276921,2333,0202,681
Total Liabilities
Total LiabilitiesCr
10,19311,76412,59513,28914,68515,60417,08319,37214,35916,05019,90821,400
Current Assets
Current AssetsCr
5,9046,8756,9896,6976,8047,3608,28210,7267,4289,29511,30012,714
Non Current Assets
Non Current AssetsCr
4,2894,8895,6076,5927,8818,2448,8018,6466,9316,7548,6088,686
Total Assets
Total AssetsCr
10,19311,76412,59513,28914,68515,60417,08319,37214,35916,05019,90821,400
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
282828282828282828282828
Reserves
ReservesCr
3,6014,4645,1355,5776,0427,0369,0589,4467,8208,82110,48411,184
Current Liabilities
Current LiabilitiesCr
3,9992,7033,2884,0214,1264,2014,6895,1055,8195,9676,3767,507
Non Current Liabilities
Non Current LiabilitiesCr
2,5644,5694,1443,6634,4894,3382,9564,4276921,2333,0202,681
Total Liabilities
Total LiabilitiesCr
10,19311,76412,59513,28914,68515,60417,08319,37214,35916,05019,90821,400
Current Assets
Current AssetsCr
5,9046,8756,9896,6976,8047,3608,28210,7267,4289,29511,30012,714
Non Current Assets
Non Current AssetsCr
4,2894,8895,6076,5927,8818,2448,8018,6466,9316,7548,6088,686
Total Assets
Total AssetsCr
10,19311,76412,59513,28914,68515,60417,08319,37214,35916,05019,90821,400

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3456571,6481,3241,3921,1311,109625-265-8283,445
Investing Cash Flow
Investing Cash FlowCr
-880-712-1,013-699-784-675-333-5284,5612-1,283
Financing Cash Flow
Financing Cash FlowCr
699543-469-739-445-442-520-77-3,906787-2,709
Net Cash Flow
Net Cash FlowCr
93199177-2971741425519389-38-547
Free Cash Flow
Free Cash FlowCr
-544-766259061645632075-1,162-1,5762,090
CFO To PAT
CFO To PAT%
46.459.3205.0143.2179.4116.6111.6-698.314.5-79.0252.9
CFO To EBITDA
CFO To EBITDA%
24.032.3102.083.582.054.347.838.3-22.2-35.275.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3456571,6481,3241,3921,1311,109625-265-8283,445
Investing Cash Flow
Investing Cash FlowCr
-880-712-1,013-699-784-675-333-5284,5612-1,283
Financing Cash Flow
Financing Cash FlowCr
699543-469-739-445-442-520-77-3,906787-2,709
Net Cash Flow
Net Cash FlowCr
93199177-2971741425519389-38-547
Free Cash Flow
Free Cash FlowCr
-544-766259061645632075-1,162-1,5762,090
CFO To PAT
CFO To PAT%
46.459.3205.0143.2179.4116.6111.6-698.314.5-79.0252.9
CFO To EBITDA
CFO To EBITDA%
24.032.3102.083.582.054.347.838.3-22.2-35.275.3

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
22,41224,20314,87418,2155,81413,10812,47713,12127,02043,45860,20274,733
Price To Earnings
Price To Earnings
30.221.818.519.77.513.513.344.241.544.251.5
Price To Sales
Price To Sales
3.02.71.61.90.61.21.01.12.33.33.54.7
Price To Book
Price To Book
6.25.42.93.31.01.91.41.43.44.95.76.7
EV To EBITDA
EV To EBITDA
17.313.711.213.35.48.16.510.122.318.813.022.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.064.558.757.758.059.657.057.355.261.167.167.1
OPM
OPM%
19.022.417.816.116.019.118.914.110.117.626.920.7
NPM
NPM%
9.812.28.99.47.38.98.1-0.8-15.57.98.09.1
ROCE
ROCE%
17.718.814.617.314.014.413.34.26.114.219.817.4
ROE
ROE%
20.524.715.616.512.813.710.9-0.9-23.311.813.012.9
ROA
ROA%
7.39.46.47.05.36.25.8-0.5-12.86.56.86.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
22,41224,20314,87418,2155,81413,10812,47713,12127,02043,45860,20274,733
Price To Earnings
Price To Earnings
30.221.818.519.77.513.513.344.241.544.251.5
Price To Sales
Price To Sales
3.02.71.61.90.61.21.01.12.33.33.54.7
Price To Book
Price To Book
6.25.42.93.31.01.91.41.43.44.95.76.7
EV To EBITDA
EV To EBITDA
17.313.711.213.35.48.16.510.122.318.813.022.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.064.558.757.758.059.657.057.355.261.167.167.1
OPM
OPM%
19.022.417.816.116.019.118.914.110.117.626.920.7
NPM
NPM%
9.812.28.99.47.38.98.1-0.8-15.57.98.09.1
ROCE
ROCE%
17.718.814.617.314.014.413.34.26.114.219.817.4
ROE
ROE%
20.524.715.616.512.813.710.9-0.9-23.311.813.012.9
ROA
ROA%
7.39.46.47.05.36.25.8-0.5-12.86.56.86.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,10,0771,03,51092,09974,73361,99459,38654,981
Close PriceClose₹2,665.001,799.002,014.002,648.005,185.00364.403,331.90
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE49.0526.0917.2451.4929.98121.8744.44
Price To SalesPS7.162.803.004.693.973.417.77
RevenueRevenueCr15,37936,91330,74615,93715,63217,4157,072
Revenue Growth TTMRev Gr TTM%13.5%13.5%24.2%-0.1%12.5%5.7%21.9%
PAT Growth TTMPAT Gr TTM%27.6%16.5%20.1%43.7%-13.2%-55.4%56.4%
Market CapitalizationMkt CapCr1,10,0771,03,51092,09974,73361,99459,38654,981
Close PriceClose₹2,665.001,799.002,014.002,648.005,185.00364.403,331.90
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE49.0526.0917.2451.4929.98121.8744.44
Price To SalesPS7.162.803.004.693.973.417.77
RevenueRevenueCr15,37936,91330,74615,93715,63217,4157,072
Revenue Growth TTMRev Gr TTM%13.5%13.5%24.2%-0.1%12.5%5.7%21.9%
PAT Growth TTMPAT Gr TTM%27.6%16.5%20.1%43.7%-13.2%-55.4%56.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 23
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 23
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews